Genetically engineered pyrroloquinoline quinone dependent glucose dehydrogenase comprising an amino acid insertion
Details for Australian Patent Application No. 2005263591 (hide)
International Classifications
Event Publications
1 February 2007 PCT application entered the National Phase
PCT publication WO2006/008132 Priority application(s): WO2006/008132
14 August 2008 Application Accepted
Published as AU-B-2005263591
11 December 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005263592-Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
2005263583-Molecular diagnostic method and treatment in dementia with lewy bodies
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser